Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920940 · ClinicalTrials.gov registry record · NA
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
A NA study of Adolescents and Bipolar Disorder I or II, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 4
- Study locations
NCT06920940: Recruiting NA study of Adolescents and Bipolar Disorder I or II, sponsored by University of California, Los Angeles.
NCT06920940 is a NA study of Adolescents and Bipolar Disorder I or II that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 80 participants, below the 3,643-participant average among 7 other Adolescents trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06920940, a NA study of Adolescents and Bipolar Disorder I or II, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 4
- Study locations
Study Summary
The present study is an open trial of ketogenic diets for adolescents and young adults (ages 12-21 yrs) in the depressive or mixed phases of bipolar disorder (BD). The investigators aim to determine whether combining standard of care pharmacological treatment for bipolar spectrum disorders with a 16-week ketogenic diet is well-tolerated and associated with improvements in depression, inflammatory and metabolic indicators, and executive functioning over the study period. The experimental treatment in this study is a 16-week full ketogenic diet. Four study sites (UCLA, U Cincinnati, U Colorado and U Pittsburgh) will recruit 80 total youth (20 each) from bipolar specialty clinics. All youth eligible for the ketogenic therapy will be provided with the ketogenic diet and standard of care pharmacological treatment. During the diet therapy youth will be seen by a study child/adolescent psychiatrist at least once a month (and more frequently when needed), with the psychiatrist recommending and providing side effects monitoring and pharmacotherapy as clinically indicated. The youth and caregivers will also meet with an expert dietitian who will coach all youth on maintaining the ketogenic diet (low carbs, high fats, medium protein) and making sure the child is tolerating the diet and getting enough liquid and nutrients, following the practice guidelines of the International Ketogenic Diet Study Group for treating youth. All youth and involved caregivers will also be provided will at least one motivational enhancement session to support them in goal setting and completion of the study elements. Throughout the study the investigators will assess metabolic (e.g., blood ketones, HOMA-IR) and inflammatory indicators (e.g., C-reactive protein), both for safety reasons and to assess correlates of symptomatic change. Independent evaluators will assess youth every month regarding their symptoms (depression, mania, anxiety, psychosis), psychosocial functioning, and quality of life.
Primary Outcome
The investigators will assess diet adherence primarily by the proportion of youth who maintain an average weekly ketone level of 1 mmol/L or above, as measured through daily blood ketone assays using the Keto Mojo device, a Bluetooth-enabled ketone and glucose testing kit.
Conditions Studied
Interventions
- OTHER Ketogenic Therapy
Study Locations (4)
California
- UCLA Semel Institute Max Gray Child and Adolescent Mood Disorders Program (CHAMP) - Los Angeles
Colorado
- University of Colorado Denver, Anschutz Medical Campus - Aurora
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Pennsylvania
- University of Pittsburgh School of Medicine - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2027-03-19 |
| Phase | NA |
What NCT06920940 shows while recruiting
NCT06920940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 3,643-participant average among 7 other Adolescents trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Adolescents appearing as the primary indexed condition, and to 1 intervention - of which Ketogenic Therapy is the first listed.
NCT06920940 reports a single indexed study location in California, Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT06920940 about?
NCT06920940 is a clinical study titled "Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents". The present study is an open trial of ketogenic diets for adolescents and young adults (ages 12-21 yrs) in the depressive or mixed phases of bipolar disorder (BD). The investigators aim to determine whether combining standard of care pharmacological treatment for bipolar spectrum disorders with a 16...
What is the current status of trial NCT06920940?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-03-19. Estimated completion is 2027-03-19.
What conditions does trial NCT06920940 study?
This clinical trial studies the following conditions: Adolescents, Bipolar Disorder I or II, Bipolar Disorder NOS, Bipolar Disorder (BD), Bipolar Spectrum Disorder.
What interventions are being tested in trial NCT06920940?
The interventions under investigation include: Ketogenic Therapy (OTHER).
Who is sponsoring clinical trial NCT06920940?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06920940 being conducted?
This trial has 4 study locations across California, Colorado, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adolescents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
RECRUITING · NA
-
Centralized Virtual SBIRT for Pediatric Primary Care
RECRUITING · NA
-
Evaluation of Trauma Center-Based Intervention for Adolescent Traumatic Injury Survivors
RECRUITING · NA
-
Sun Protection and Tanning Awareness in Rural Schools
COMPLETED · NA
-
Exercise and Endocannabinoids for Brain and Mental Health
COMPLETED · NA
-
Sun-safe Habits Intervention and Education
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI